FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting
about
McCune-Albright syndromeThe FGF23-Klotho axis: endocrine regulation of phosphate homeostasisEffects of PTH on osteocyte functionFGF23-mediated regulation of systemic phosphate homeostasis: is Klotho an essential player?Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF familyFGF23 in Acute and Chronic IllnessFibroblast growth factor receptor signaling in hereditary and neoplastic disease: biologic and clinical implicationsMiscellaneous non-inflammatory musculoskeletal conditions. Hyperphosphatemic familial tumoral calcinosis (FGF23, GALNT3 and αKlotho)FGF23 and Phosphate Wasting DisordersSkeletal secretion of FGF-23 regulates phosphate and vitamin D metabolismFibroblast Growth Factor 23: A New Dimension to Diseases of Calcium-Phosphorus MetabolismRole of FGF23 in vitamin D and phosphate metabolism: implications in chronic kidney diseaseMcCune-Albright syndrome and the extraskeletal manifestations of fibrous dysplasiaFibrous dysplasia and fibroblast growth factor-23 regulationArterial stiffness, vascular calcification and bone metabolism in chronic kidney diseaseCalcium and phosphate impact cardiovascular risk.Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient miceRole of matrix extracellular phosphoglycoprotein in the pathogenesis of X-linked hypophosphatemiaRegulation of fibroblast growth factor-23 signaling by klothoBone and muscle: Interactions beyond mechanical.Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolismFGF-23 in bone biology.Circulating fibroblast growth factor 23 in patients with end-stage renal disease treated by peritoneal dialysis is intact and biologically activeIs fibroblast growth factor receptor 4 a suitable target of cancer therapy?"Mesenchymal" stem cells in human bone marrow (skeletal stem cells): a critical discussion of their nature, identity, and significance in incurable skeletal disease.Effects of Different 1-34 Parathyroid Hormone Dosages on Fibroblast Growth Factor-23 Secretion in Human Bone Marrow Cells following Osteogenic Differentiation.Transfer, analysis, and reversion of the fibrous dysplasia cellular phenotype in human skeletal progenitors.Stem cells and bone diseases: new tools, new perspectiveOsteoblast-specific expression of the fibrous dysplasia (FD)-causing mutation Gsα(R201C) produces a high bone mass phenotype but does not reproduce FD in the mouse.Mutations that cause osteoglophonic dysplasia define novel roles for FGFR1 in bone elongationThe calcemic response to continuous parathyroid hormone (PTH)(1-34) infusion in end-stage kidney disease varies according to bone turnover: a potential role for PTH(7-84)FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1.Establishment of sandwich ELISA for soluble alpha-Klotho measurement: Age-dependent change of soluble alpha-Klotho levels in healthy subjectsHypophosphatemic rickets: revealing novel control points for phosphate homeostasis.Analysis of the biochemical mechanisms for the endocrine actions of fibroblast growth factor-23Tumor-induced osteomalacia.The changing face of hypophosphatemic disorders in the FGF-23 eraFracture incidence in polyostotic fibrous dysplasia and the McCune-Albright syndrome.Applicability of fibroblast growth factor 23 for evaluation of risk of vertebral fracture and chronic kidney disease-mineral bone disease in elderly chronic kidney disease patientsRelationship between Fibroblast Growth Factor-23 and Mineral Metabolism in Chronic Kidney Disease
P2860
Q21202914-68467A24-2D17-4965-8A0B-57746EC1F2B0Q24625902-A345A5F6-2528-405B-BAB8-25EDCD77D237Q24631082-279166A0-A4DF-4CA4-8D50-F8A762523B45Q24653541-B22702AE-A70D-4DD1-83B2-CA466AEE6E56Q24676527-1ED473C6-54EC-494D-BF88-7F00EB5AF24BQ26778554-3B8CE17E-8436-472B-9D52-429D69D8F0DEQ26801718-61906F89-E724-4C27-80DF-D7B74ADBE4FCQ26827280-47985EE0-A3CF-4643-A315-B8BBE7C1BE1AQ26851904-A1023D7E-409B-4776-B4D7-3D3D606AE83FQ26852624-E3A6D7CA-CC57-4F15-85B7-F428CE70F2C5Q26866263-0017973F-444A-4C2B-B752-401EE46F3DF6Q27000415-6D4E740C-DE33-42E1-A1D3-560F558B02E0Q27000779-F2A71A3F-3436-473A-BA72-5F0A7A88EBB6Q27010789-BD64F56F-3B5A-4B3A-A0F8-48088F41A129Q27024623-DF697F23-8353-4673-8193-4CEA09D652E4Q27687570-DA8B9117-62BE-4977-9E6D-32C2660B6FCBQ28507303-87FA0639-A66C-42BE-AC52-3FF09F51AA98Q28511009-EA783BD0-39AD-4FE6-B0C9-7A44867577F3Q28587100-1BC7C1BA-C8CE-425F-9D0F-651F857AD204Q28606563-29C125FE-7D64-4073-AF4A-3EE0BBF34669Q29620323-29E2B928-0C53-43B1-B599-55E2E48CE4DFQ33684986-4CDEB934-2828-4993-ABED-3688CCAC03FBQ33736093-360B4942-AFB4-4E9D-9F43-8D95A9770E76Q33751398-698FF0D7-06CE-40DF-80FA-EC1354732FF9Q33800712-222799DF-4A0A-4306-BB22-797EEBFDFD54Q33851227-F86B92BF-C7B5-4E2C-828D-670EA243AD84Q33925044-9B8867BA-8EB0-41AD-A0FE-58F39B5B9362Q33925049-A20FD67A-C33C-425E-98FB-901E3613F6CCQ33926385-5509A3B7-B264-419F-BC8F-FDF8207B8265Q33938586-4E66E0E4-3C80-4491-B3F3-3D272104C4C1Q33984825-2E0AF07C-91A9-46EA-9F00-CDA82D286D46Q34017992-2EA9B348-E4A7-480D-94C3-5B4D0944BBFEQ34034905-EDC68C82-CFE8-4CAB-9CC2-9380757B4BB3Q34069793-DD1B5BA5-4352-4784-9089-23C2EB6494B1Q34075026-6FE860D0-F24C-4309-84C0-38B23884FA3AQ34178089-5AB2B964-5651-4FCD-ADA4-8759D0467C56Q34221238-ADE59AF1-0FAD-4BCE-8FA1-020BD55734F3Q34303726-A74D6360-5B69-49D3-9B86-90AE19225588Q34421862-7CDF7514-09E8-4CEB-8271-2B90E99E5055Q34479134-ED815F81-561A-4755-B9B2-BF4505E6F5F1
P2860
FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting
@ast
FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting
@en
FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting
@nl
type
label
FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting
@ast
FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting
@en
FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting
@nl
prefLabel
FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting
@ast
FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting
@en
FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting
@nl
P2093
P2860
P50
P356
P1476
FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting
@en
P2093
Alessandro Corsi
Anurag Gupta
Kenneth E White
Mara Riminucci
Michael T Collins
Natasha Cherman
Paolo Bianco
Steven Waguespack
P2860
P304
P356
10.1172/JCI18399
P407
P577
2003-09-01T00:00:00Z